Regeneron Pharmaceuticals, Inc. (0R2M)
Market Open
10 Aug, 15:30
$
802. 20
+17.91
+2.2836%
$
- Market Cap
24.52 P/E Ratio
0.22% Div Yield
1,867 Volume
42.79 Eps
$ 784.29
Previous Close Want to track 0R2M and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0R2M Earnings Reports FAQ
What is the earnings per share (EPS) for 0R2M?
The current EPS is 42.79.
What is the company's earnings growth rate?
Regeneron Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Regeneron Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Regeneron Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0R2M at this time, as Regeneron Pharmaceuticals, Inc has no recent EPS data to calculate it.
